Related Experiment Video
Updated: Jan 20, 2026

Identifying Cell Surface Markers of Primary Neural Stem and Progenitor Cells by Metabolic Labeling of Sialoglycan
Published on: September 7, 2019
Markers for Identifying and Targeting Glioblastoma Cells during Surgery
Stephanie Schipmann1, Michael Schwake1, Eric Suero Molina1
1Department of Neurosurgery, University Hospital Münster, Münster, Germany.
Abstract:
Glioblastoma is a highly malignant tumor with a poor prognosis. A factor influencing survival that can be affected by the surgeon is the extent of resection (EOR). Due to the infiltrative nature of the tumor, delineation of tumor from normal brain parenchyma is often challenging. To improve EOR and facilitate tumor visualization, several techniques have been developed over the last few years. This literature review presents an overview of current intraoperative strategies for identifying and targeting glioma cells and discusses the benefits and limitations of each technique. Along with conventional techniques such as neuronavigation and ultrasound, fluorescence-guided surgery with different fluorescent agents such as 5-aminolevulinc acid and fluorescein have been widely used. Recently, newer techniques have emerged and are being translated into the operating room, promising delineation of glioblastoma tissue using targeted approaches or identification on a microscopic level, for instance using Raman spectroscopy or confocal microscopy.
Related Concept Videos
11:39Identifying Cell Surface Markers of Primary Neural Stem and Progenitor Cells by Metabolic Labeling of Sialoglycan
10:41Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
09:10An Immunocompetent Murine Model for Laser Interstitial Thermal Therapy of Glioblastoma
04:13Co-Culturing Glioblastoma Cells on Patterned Neurons: A Technique to Monitor the Migration of Glioblastoma Cells on Rat Hippocampal Neurons In Vitro
09:29Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain
09:57Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model

